The French government stops the use of malaria drug hydroxychloroquine for treating COVID-19 patients after a new study suggested it doesn’t work and poses health risks.
A decree ending its use for the coronavirus in France is published Wednesday.
The World Health Organization did the same after a study of 100,000 patients worldwide published last week found that the drug was ineffective against the virus and tied to a greater risk of death and heart rhythm problems.
The drug has been popular and politically sensitive in France, where it was included in a trial of multiple treatments and used on hospitalized patients.
US President Donald Trump started pushing hydroxychloroquine based on early research by prominent French virologist Dr. Didier Raoult suggesting it reduced virus symptoms.
Raoult shrugged off guidance from France’s High Council for Public Health to stop use of the drug, suggesting it’s not important now that the number of infected people is no longer at crisis levels. The council’s recommendation is “one opinion like any other, I don’t care much,” he told France’s LCI television Tuesday night.
— AP
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Wednesday, May 27, 2020
Add ToI as a Preferred Source on Google
